Henlius partners with Sandoz for 10 biosimilar antibodies
August 18, 2026 | 14:33
Biotechnology company Henlius entered a strategic collaboration with Sandoz on 17 August 2026 covering up to 10 proposed monoclonal antibody biosimilars for global distribution.
Mobile Version